At the Center for Genomic Medicine, we are collecting genomic DNA samples from patients and the general population, through the cooperation of medical institutions, and are locating genes associated with disease susceptibility and drug responsiveness, using analyses of SNP typing data as a guide. We are also collaborating with universities, research institutions, and pharmaceutical companies on investigative research into the function of these genes.
Our ultimate objective is to understand the mechanisms behind disease onset, therapeutic action, and side effects, so that this knowledge can be applied to the development of new drugs or new methods to prevent or treat the underlying disease. We are actively pursuing joint research with pharmaceutical companies and other organizations, so that the results of our research can be applied as quickly as possible to the development of new drugs, diagnostics, and other therapeutic methods. Moreover, in cooperation with medical institutions, we are working on the rapid development and adoption of new treatment and preventive techniques.